These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 30066885

  • 1. Inhibition of eIF4F complex loading inhibits the survival of malignant glioma.
    Dong QF, Yan ZF, Li PQ, Yang X, Huo JL, Zhen HN.
    Oncol Rep; 2018 Oct; 40(4):2399-2407. PubMed ID: 30066885
    [Abstract] [Full Text] [Related]

  • 2. Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas.
    Oblinger JL, Burns SS, Akhmametyeva EM, Huang J, Pan L, Ren Y, Shen R, Miles-Markley B, Moberly AC, Kinghorn AD, Welling DB, Chang LS.
    Neuro Oncol; 2016 Sep; 18(9):1265-77. PubMed ID: 26951381
    [Abstract] [Full Text] [Related]

  • 3. Anti-Cancer Effect of Cap-Translation Inhibitor 4EGI-1 in Human Glioma U87 Cells: Involvement of Mitochondrial Dysfunction and ER Stress.
    Wu M, Zhang C, Li XJ, Liu Q, Wanggou S.
    Cell Physiol Biochem; 2016 Sep; 40(5):1013-1028. PubMed ID: 27941351
    [Abstract] [Full Text] [Related]

  • 4. Targeting the eIF4F translation initiation complex for cancer therapy.
    Konicek BW, Dumstorf CA, Graff JR.
    Cell Cycle; 2008 Aug 15; 7(16):2466-71. PubMed ID: 18719377
    [Abstract] [Full Text] [Related]

  • 5. Antitumor activity of tetrandrine citrate in human glioma U87 cells in vitro and in vivo.
    Sun J, Zhang Y, Zhen Y, Cui J, Hu G, Lin Y.
    Oncol Rep; 2019 Dec 15; 42(6):2345-2354. PubMed ID: 31638254
    [Abstract] [Full Text] [Related]

  • 6. Knockdown of PEBP4 inhibits human glioma cell growth and invasive potential via ERK1/2 signaling pathway.
    Huang RQ, Wang SQ, Zhu QB, Guo SC, Shi DL, Chen F, Fang YC, Chen R, Lu YC.
    Mol Carcinog; 2019 Jan 15; 58(1):135-143. PubMed ID: 30255656
    [Abstract] [Full Text] [Related]

  • 7. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
    Demosthenous C, Han JJ, Stenson MJ, Maurer MJ, Wellik LE, Link B, Hege K, Dogan A, Sotomayor E, Witzig T, Gupta M.
    Oncotarget; 2015 Apr 20; 6(11):9488-501. PubMed ID: 25839159
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-383 expression regulates proliferation, migration, invasion, and apoptosis in human glioma cells.
    Xu D, Ma P, Gao G, Gui Y, Niu X, Jin B.
    Tumour Biol; 2015 Sep 20; 36(10):7743-53. PubMed ID: 25936342
    [Abstract] [Full Text] [Related]

  • 9. RNA interference-mediated silencing of focal adhesion kinase inhibits growth of human malignant glioma xenograft in nude mice.
    Wang GJ, Ma YP, Yang Y, Zhang N, Wang W, Liu SY, Chen LJ, Jiang Y, Zhao X, Wei YQ, Deng HX.
    Cell Biol Int; 2011 Aug 20; 35(8):841-8. PubMed ID: 21247411
    [Abstract] [Full Text] [Related]

  • 10. Moxidectin inhibits glioma cell viability by inducing G0/G1 cell cycle arrest and apoptosis.
    Song D, Liang H, Qu B, Li Y, Liu J, Chen C, Zhang D, Zhang X, Gao A.
    Oncol Rep; 2018 Sep 20; 40(3):1348-1358. PubMed ID: 30015956
    [Abstract] [Full Text] [Related]

  • 11. Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells.
    Conde M, Michen S, Wiedemuth R, Klink B, Schröck E, Schackert G, Temme A.
    BMC Cancer; 2017 Dec 28; 17(1):889. PubMed ID: 29282022
    [Abstract] [Full Text] [Related]

  • 12. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
    Guo M, Jiang Z, Zhang X, Lu D, Ha AD, Sun J, Du W, Wu Z, Hu L, Khadarian K, Shen J, Lin Z.
    Carcinogenesis; 2014 Aug 28; 35(8):1698-706. PubMed ID: 24480809
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1.
    Xue H, Guo X, Han X, Yan S, Zhang J, Xu S, Li T, Guo X, Zhang P, Gao X, Liu Q, Li G.
    Oncotarget; 2016 Jan 26; 7(4):4785-805. PubMed ID: 26715733
    [Abstract] [Full Text] [Related]

  • 14. Autophagy involvement in olanzapine-mediated cytotoxic effects in human glioma cells.
    Wang YX, Xu SQ, Chen XH, Liu RS, Liang ZQ.
    Asian Pac J Cancer Prev; 2014 Jan 26; 15(19):8107-13. PubMed ID: 25338992
    [Abstract] [Full Text] [Related]

  • 15. SBI-0640756 Attenuates the Growth of Clinically Unresponsive Melanomas by Disrupting the eIF4F Translation Initiation Complex.
    Feng Y, Pinkerton AB, Hulea L, Zhang T, Davies MA, Grotegut S, Cheli Y, Yin H, Lau E, Kim H, De SK, Barile E, Pellecchia M, Bosenberg M, Li JL, James B, Hassig CA, Brown KM, Topisirovic I, Ronai ZA.
    Cancer Res; 2015 Dec 15; 75(24):5211-8. PubMed ID: 26603897
    [Abstract] [Full Text] [Related]

  • 16. B-cell CLL/lymphoma 3 promotes glioma cell proliferation and inhibits apoptosis through the oncogenic STAT3 pathway.
    Wu J, Li L, Jiang G, Zhan H, Wang N.
    Int J Oncol; 2016 Dec 15; 49(6):2471-2479. PubMed ID: 27748795
    [Abstract] [Full Text] [Related]

  • 17. Upregulation of p-Smad2 contributes to FAT10-induced oncogenic activities in glioma.
    Dai B, Zhang Y, Zhang P, Pan C, Xu C, Wan W, Wu Z, Zhang J, Zhang L.
    Tumour Biol; 2016 Jul 15; 37(7):8621-31. PubMed ID: 26733179
    [Abstract] [Full Text] [Related]

  • 18. The ERK/eIF4F/Bcl-XL pathway mediates SGP-2 induced osteosarcoma cells apoptosis in vitro and in vivo.
    Zhang Z, Zheng Y, Zhu R, Zhu Y, Yao W, Liu W, Gao X.
    Cancer Lett; 2014 Oct 01; 352(2):203-13. PubMed ID: 25025927
    [Abstract] [Full Text] [Related]

  • 19. Knockdown of ILK inhibits glioma development via upregulation of E-cadherin and downregulation of cyclin D1.
    Zheng K, Wang G, Li C, Shan X, Liu H.
    Oncol Rep; 2015 Jul 01; 34(1):272-8. PubMed ID: 25998224
    [Abstract] [Full Text] [Related]

  • 20. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K, Wang R, Wang X, Lin F, Shen JJ, Gao P, Zhang HZ.
    Breast Cancer Res Treat; 2009 Feb 01; 113(3):443-56. PubMed ID: 18327707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.